1. Home
  2. VERA vs CUBI Comparison

VERA vs CUBI Comparison

Compare VERA & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • CUBI
  • Stock Information
  • Founded
  • VERA 2016
  • CUBI 1994
  • Country
  • VERA United States
  • CUBI United States
  • Employees
  • VERA N/A
  • CUBI N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • CUBI Major Banks
  • Sector
  • VERA Health Care
  • CUBI Finance
  • Exchange
  • VERA Nasdaq
  • CUBI Nasdaq
  • Market Cap
  • VERA 2.5B
  • CUBI 1.4B
  • IPO Year
  • VERA 2021
  • CUBI 2012
  • Fundamental
  • Price
  • VERA $42.01
  • CUBI $46.46
  • Analyst Decision
  • VERA Strong Buy
  • CUBI Buy
  • Analyst Count
  • VERA 9
  • CUBI 8
  • Target Price
  • VERA $53.56
  • CUBI $63.86
  • AVG Volume (30 Days)
  • VERA 683.6K
  • CUBI 290.2K
  • Earning Date
  • VERA 11-07-2024
  • CUBI 10-31-2024
  • Dividend Yield
  • VERA N/A
  • CUBI N/A
  • EPS Growth
  • VERA N/A
  • CUBI 33.08
  • EPS
  • VERA N/A
  • CUBI 7.41
  • Revenue
  • VERA N/A
  • CUBI $722,462,000.00
  • Revenue This Year
  • VERA N/A
  • CUBI N/A
  • Revenue Next Year
  • VERA N/A
  • CUBI $11.71
  • P/E Ratio
  • VERA N/A
  • CUBI $6.12
  • Revenue Growth
  • VERA N/A
  • CUBI 25.87
  • 52 Week Low
  • VERA $9.68
  • CUBI $38.69
  • 52 Week High
  • VERA $50.78
  • CUBI $68.49
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • CUBI 48.18
  • Support Level
  • VERA $39.22
  • CUBI $44.31
  • Resistance Level
  • VERA $50.00
  • CUBI $47.11
  • Average True Range (ATR)
  • VERA 2.41
  • CUBI 1.57
  • MACD
  • VERA 0.24
  • CUBI 0.05
  • Stochastic Oscillator
  • VERA 28.53
  • CUBI 28.96

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources, and Financial Products and Services. The majority of revenue is derived from commercial lending.

Share on Social Networks: